102676-60-8 Usage
Description
Methyl 3-(1-Tritylimidazol-4-yl) Propionate, with the CAS number 102676-60-8, is a white solid compound that is primarily utilized in the field of organic synthesis. It is known for its unique chemical properties that make it a valuable component in various chemical reactions and processes.
Uses
Used in Organic Synthesis:
Methyl 3-(1-Tritylimidazol-4-yl) Propionate is used as a synthetic building block for the creation of more complex organic molecules. Its trityl-protected imidazole group provides a versatile handle for further functionalization and modification, making it a valuable intermediate in the synthesis of various organic compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Methyl 3-(1-Tritylimidazol-4-yl) Propionate is used as a key intermediate in the development of new drugs. Its unique chemical structure allows for the design and synthesis of novel drug candidates with potential therapeutic applications.
Used in Chemical Research:
Methyl 3-(1-Tritylimidazol-4-yl) Propionate is also used in academic and industrial research settings to study various aspects of organic chemistry, such as reaction mechanisms, stereochemistry, and the development of new synthetic methods.
Check Digit Verification of cas no
The CAS Registry Mumber 102676-60-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,6,7 and 6 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 102676-60:
(8*1)+(7*0)+(6*2)+(5*6)+(4*7)+(3*6)+(2*6)+(1*0)=108
108 % 10 = 8
So 102676-60-8 is a valid CAS Registry Number.
InChI:InChI=1/C26H24N2O2/c1-30-25(29)18-17-24-19-28(20-27-24)26(21-11-5-2-6-12-21,22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,19-20H,17-18H2,1H3
102676-60-8Relevant articles and documents
3,4,5-TRISUBSTITUTED-1,2,4-TRIAZOLES AND 3,4,5-TRISUBSTITUTED-3-THIO-1,2,4-TRIAZOLES AND USES THEREOF
-
Paragraph 0158; 0162, (2018/12/02)
The present disclosure describes novel compounds that are somatostatin receptor type 4 agonists.
1,(3,)5-substituted imidazoles, useful in the treatment of hypertension and methods for their preparation
-
Paragraph 0204; 0207; 0210; 0212, (2016/03/04)
The present invention provides novel 1,5 and 1,3,5-substituted imidazole compounds in hydrophilic or lipophilic form, which are useful as angiotensin II ATI receptor antagonists suitable for transdermal delivery. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing compounds and their use in methods of treating hypertension and cardiovascular diseases.
N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
-
Page/Page column 6-7, (2009/09/26)
The invention relates to the use of a N-benzyl 5-substituted imidazole derivative having the general formula I wherein R is (C1-3)alkyl, (C1-3)alkyloxy, halogen, nitro or cyano; R1 is (C1-6)alkyl, optionally substituted with OH, (C1-3)alkyloxy, (C1-3)alkylcarbonyloxy, (C1-3)alkyloxycarbonyl or halogen, or (C1-3)alkyloxycarbonyl; or R1 is phenyl, optionally substituted with 1-3 substituents independently selected from (C1-3)alkyl, (C1-3)alkyloxy, hydroxylmethyl and halogen; or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for the treatment of a disorder or disease in a subject mediated by aldosterone synthase or responsive to inhibition of aldosterone synthase.